Social Capital Suvretta Holdings Corp. II (DNAB)
| Market Cap | 309.33M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -746,825 |
| Shares Out | 31.89M |
| EPS (ttm) | -0.04 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4 |
| Open | 9.70 |
| Previous Close | 9.70 |
| Day's Range | 9.70 - 9.70 |
| 52-Week Range | 9.60 - 10.35 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About DNAB
Social Capital Suvretta Holdings Corp. II does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in biotechnology industry. The company was incorporated in 2021 and is based in Henderson, Nevada. [Read more...]
News
Social Capital Suvretta Holdings Corp. II Announces Pricing of Upsized $220,000,000 Initial Public Offering
Social Capital Suvretta Holdings Corp. II (the "Company") announced today that it has priced its upsized initial public offering of 22,000,000 Class A ordinary shares at $10.00 per share.
Chamath Palihapitiya Launches 4 New Biotech SPACs: What Investors Should Know
One of the most famous voices in the SPAC industry is launching four new SPACs and also making several changes to his existing lineup of SPACs and former
Chamath Files 4 New Biotech SPACs
Today's SPAC highlight came post market as Chamath dropped four new SPAC S-1s for $800M total. JWS vote passes, with TSIA and JIH set to vote tomorrow.
Four Palihapitiya-backed SPACs look to raise $800 mln through IPOs
Four blank-check companies, backed by venture investor Chamath Palihapitiya, are looking to raise a total of $800 million through initial public offerings with a focus on acquiring biotechnology firms, ...
Social Capital Suvretta Holdings II IPO Registration Document (S-1)
Social Capital Suvretta Holdings Corp. II has filed to go public with an IPO on the NASDAQ.